Lv63
1930 积分 2022-05-24 加入
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
55分钟前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
58分钟前
已完结
结缔组织病相关间质性肺病中西医结合诊治指南(2025版)
1天前
已完结
Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): a network meta-analysis of randomized controlled trials
2天前
已完结
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial
7天前
已完结
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial
7天前
已完结
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
7天前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
14天前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
14天前
已完结
皖公网安备34019202002308
